Zydus Lifesciences Limited — PPTs, 11-03-2025: Investor Presentation

Zydus Lifesciences has plans to acquire Amplitude Surgical SA, a leading orthopaedics player in Europe, for approximately €257 million, which accounts for an 85.6% stake. The intended acquisition aims to enhance Zydus' global MedTech strategy, tapping into the growing medical device market projected to reach $670 billion globally by 2029. Amplitude Surgical generated €106 million in FY24 revenue and boasts a solid EBITDA margin of 25.6%. This acquisition allows Zydus to leverage Amplitude's robust R&D capabilities and extensive product portfolio to capture future growth opportunities. Zydus plans to fund the acquisition through a blend of internal resources and external financing, with expected completion by June 2025, subject to regulatory approvals. The existing management team at Amplitude will remain post-acquisition, positioning Zydus to integrate further into the orthopaedics market while expanding its footprint in MedTech.